Half-year report · Q2
3604.TEDINET S100UQYU
Period2024-04-01 → 2024-09-30
Filed2024-11-13
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 44
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥16.2bn | 2024-04-01 → 2024-09-30 | Cons. | Net sales |
| Revenue | ¥29.6bn | 2023-04-01 → 2024-03-31 | Cons. | Net sales (5-year summary) |
| Revenue | ¥14.6bn | 2023-04-01 → 2023-09-30 | Cons. | Net sales |
| Operating income | ¥304m | 2024-04-01 → 2024-09-30 | Cons. | Operating income |
| Operating income | ¥100m | 2023-04-01 → 2023-09-30 | Cons. | Operating income |
| Ordinary income | ¥340m | 2024-04-01 → 2024-09-30 | Cons. | Ordinary income |
| Ordinary income | ¥564m | 2023-04-01 → 2024-03-31 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥218m | 2023-04-01 → 2023-09-30 | Cons. | Ordinary income |
| Profit before tax | ¥328m | 2024-04-01 → 2024-09-30 | Cons. | Income before income taxes |
| Profit before tax | ¥289m | 2023-04-01 → 2023-09-30 | Cons. | Income before income taxes |
| Net income (owners) | ¥239m | 2024-04-01 → 2024-09-30 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥402m | 2023-04-01 → 2024-03-31 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥179m | 2023-04-01 → 2023-09-30 | Cons. | Profit loss attributable to owners of parent |
| Net income | ¥225m | 2024-04-01 → 2024-09-30 | Cons. | Profit loss |
| Net income | ¥208m | 2023-04-01 → 2023-09-30 | Cons. | Profit loss |
| Total assets | ¥20.4bn | at 2024-09-30 | Cons. | Assets |
| Total assets | ¥19.5bn | at 2024-03-31 | Cons. | Assets |
| Total assets | ¥19.5bn | at 2023-09-30 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥12.4bn | at 2024-09-30 | Cons. | Liabilities |
| Total liabilities | ¥11.8bn | at 2024-03-31 | Cons. | Liabilities |
| Net assets / equity | ¥8.0bn | at 2024-09-30 | Cons. | Net assets |
| Net assets / equity | ¥7.8bn | at 2024-03-31 | Cons. | Net assets |
| Net assets / equity | ¥7.5bn | at 2023-09-30 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥1.5bn | at 2024-09-30 | Cons. | Cash and deposits |
| Cash and deposits | ¥1.5bn | at 2024-03-31 | Cons. | Cash and deposits |
| Cash & equivalents | ¥1.3bn | at 2024-09-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥1.2bn | at 2024-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥1.6bn | at 2023-09-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥1.5bn | at 2023-03-31d | Cons. | Cash and cash equivalents |
| Operating cash flow | −¥260m | 2024-04-01 → 2024-09-30 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥592m | 2023-04-01 → 2024-03-31 | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥339m | 2023-04-01 → 2023-09-30 | Cons. | Net cash provided by used in operating activities |
| Investing cash flow | ¥42m | 2024-04-01 → 2024-09-30 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥576m | 2023-04-01 → 2024-03-31 | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥205m | 2023-04-01 → 2023-09-30 | Cons. | Net cash provided by used in investment activities |
| Financing cash flow | ¥351m | 2024-04-01 → 2024-09-30 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | −¥344m | 2023-04-01 → 2024-03-31 | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | ¥4m | 2023-04-01 → 2023-09-30 | Cons. | Net cash provided by used in financing activities |
| EPS (basic) | ¥41.18 | 2024-04-01 → 2024-09-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥69.32 | 2023-04-01 → 2024-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥30.84 | 2023-04-01 → 2023-09-30 | Cons. | Basic earnings loss per share (5-year summary) |
| Equity ratio | 36.0% | at 2024-09-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 36.2% | at 2024-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 34.9% | at 2023-09-30 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 20
| Segment | Item | Period | Value |
|---|---|---|---|
| Reconciling Itemsreconciling | segment ordinary income | 2024-04-01 → 2024-09-30 | −¥328m |
| jpcrp040300-q2r_E00614-000Consumerreportable segment | revenue | 2024-04-01 → 2024-09-30 | ¥11.7bn |
| jpcrp040300-q2r_E00614-000Consumerreportable segment | revenue external | 2024-04-01 → 2024-09-30 | ¥11.7bn |
| jpcrp040300-q2r_E00614-000Consumerreportable segment | segment ordinary income | 2024-04-01 → 2024-09-30 | ¥426m |
| jpcrp040300-q2r_E00614-000Medicalreportable segment | revenue | 2024-04-01 → 2024-09-30 | ¥4.5bn |
| jpcrp040300-q2r_E00614-000Medicalreportable segment | revenue external | 2024-04-01 → 2024-09-30 | ¥4.5bn |
| jpcrp040300-q2r_E00614-000Medicalreportable segment | segment ordinary income | 2024-04-01 → 2024-09-30 | ¥241m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2024-04-01 → 2024-09-30 | ¥16.2bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2024-04-01 → 2024-09-30 | ¥16.2bn |
| Total Of Reportable Segments And Otherssegment total | segment ordinary income | 2024-04-01 → 2024-09-30 | ¥668m |
| Reconciling Itemsreconciling | segment ordinary income | 2023-04-01 → 2023-09-30 | −¥294m |
| jpcrp040300-q2r_E00614-000Consumerreportable segment | revenue | 2023-04-01 → 2023-09-30 | ¥10.5bn |
| jpcrp040300-q2r_E00614-000Consumerreportable segment | revenue external | 2023-04-01 → 2023-09-30 | ¥10.5bn |
| jpcrp040300-q2r_E00614-000Consumerreportable segment | segment ordinary income | 2023-04-01 → 2023-09-30 | ¥389m |
| jpcrp040300-q2r_E00614-000Medicalreportable segment | revenue | 2023-04-01 → 2023-09-30 | ¥4.1bn |
| jpcrp040300-q2r_E00614-000Medicalreportable segment | revenue external | 2023-04-01 → 2023-09-30 | ¥4.1bn |
| jpcrp040300-q2r_E00614-000Medicalreportable segment | segment ordinary income | 2023-04-01 → 2023-09-30 | ¥123m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2023-04-01 → 2023-09-30 | ¥14.6bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2023-04-01 → 2023-09-30 | ¥14.6bn |
| Total Of Reportable Segments And Otherssegment total | segment ordinary income | 2023-04-01 → 2023-09-30 | ¥512m |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 510
| Item | Context | Value | Unit |
|---|---|---|---|
| Number of shares held | CurrentQuarterInstant_No2MajorShareholdersMember | 269000 | |
| Shareholding ratio | CurrentQuarterInstant_No2MajorShareholdersMember | 0.0465 | |
| Number of shares held | CurrentQuarterInstant_No3MajorShareholdersMember | 236000 | |
| Shareholding ratio | CurrentQuarterInstant_No3MajorShareholdersMember | 0.0407 | |
| Number of shares held | CurrentQuarterInstant_No4MajorShareholdersMember | 234000 | |
| Shareholding ratio | CurrentQuarterInstant_No4MajorShareholdersMember | 0.0404 | |
| Number of shares held | CurrentQuarterInstant_No5MajorShareholdersMember | 89000 | |
| Shareholding ratio | CurrentQuarterInstant_No5MajorShareholdersMember | 0.0155 | |
| Number of shares held | CurrentQuarterInstant_No6MajorShareholdersMember | 79000 | |
| Shareholding ratio | CurrentQuarterInstant_No6MajorShareholdersMember | 0.0136 | |
| Number of shares held | CurrentQuarterInstant_No7MajorShareholdersMember | 45000 | |
| Shareholding ratio | CurrentQuarterInstant_No7MajorShareholdersMember | 0.0078 | |
| Number of shares held | CurrentQuarterInstant_No8MajorShareholdersMember | 36000 | |
| Shareholding ratio | CurrentQuarterInstant_No8MajorShareholdersMember | 0.0062 | |
| Number of shares held | CurrentQuarterInstant_No9MajorShareholdersMember | 33000 | |
| Shareholding ratio | CurrentQuarterInstant_No9MajorShareholdersMember | 0.0058 | |
| Number of shares held | CurrentQuarterInstant_No10MajorShareholdersMember | 28000 | |
| Shareholding ratio | CurrentQuarterInstant_No10MajorShareholdersMember | 0.0048 | |
| Number of shares held | CurrentQuarterInstant | 3955000 | |
| Shareholding ratio | CurrentQuarterInstant | 0.6824 | |
| Number of shares issued shares voting rights | CurrentQuarterInstant_SharesWithNoVotingRightsMember | － | |
| Number of shares issued shares voting rights | CurrentQuarterInstant_SharesWithRestrictedVotingRightsTreasurySharesEtcMember | － | |
| Number of shares issued shares voting rights | CurrentQuarterInstant_SharesWithRestrictedVotingRightsOtherMember | － | |
| Number of voting rights issued shares voting rights | CurrentQuarterInstant_SharesWithRestrictedVotingRightsOtherMember | － | |
| Number of shares issued shares voting rights | CurrentQuarterInstant_OrdinarySharesTreasurySharesSharesWithFullVotingRightsTreasurySharesEtcMember | 204400 | |
| Number of shares issued shares voting rights | CurrentQuarterInstant_OrdinarySharesSharesWithFullVotingRightsOtherMember | 5790100 | |
| Number of voting rights issued shares voting rights | CurrentQuarterInstant_OrdinarySharesSharesWithFullVotingRightsOtherMember | 57901 | |
| Number of shares issued shares voting rights | CurrentQuarterInstant_OrdinarySharesSharesLessThanOneUnitMember | 5500 | |
| Number of shares issued shares voting rights | CurrentQuarterInstant | 6000000 | |
| Number of voting rights issued shares voting rights | CurrentQuarterInstant | 57901 | |
| Number of shares held in own name treasury shares etc | CurrentQuarterInstant_Row1Member | 204400 | |
| Number of shares held in others names treasury shares etc | CurrentQuarterInstant_Row1Member | － | |
| Total number of shares held treasury shares etc | CurrentQuarterInstant_Row1Member | 204400 | |
| Shareholding ratio treasury shares etc | CurrentQuarterInstant_Row1Member | 0.0341 | |
| Number of shares held in own name treasury shares etc | CurrentQuarterInstant | 204400 | |
| Number of shares held in others names treasury shares etc | CurrentQuarterInstant | － | |
| Total number of shares held treasury shares etc | CurrentQuarterInstant | 204400 | |
| Shareholding ratio treasury shares etc | CurrentQuarterInstant | 0.0341 | |
| Cash and deposits | Prior1YearInstant | 1501588000 | JPY |
| Cash and deposits | CurrentQuarterInstant | 1496762000 | JPY |
| Notes and accounts receivable trade | Prior1YearInstant | 4736847000 | JPY |
| Notes and accounts receivable trade | CurrentQuarterInstant | 4703882000 | JPY |
| Electronically recorded monetary claims operating ca | Prior1YearInstant | 4830345000 | JPY |
| Electronically recorded monetary claims operating ca | CurrentQuarterInstant | 5320289000 | JPY |
| Short term investment securities | Prior1YearInstant | 2291000 | JPY |
| Short term investment securities | CurrentQuarterInstant | 2534000 | JPY |
| Merchandise and finished goods | Prior1YearInstant | 2130585000 | JPY |
| Merchandise and finished goods | CurrentQuarterInstant | 2240977000 | JPY |
| Work in process | Prior1YearInstant | 342071000 | JPY |
| Work in process | CurrentQuarterInstant | 523948000 | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 14 of 14 passed
| balance sheet identity | pass rounding |
| balance sheet identity | pass rounding |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |